MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin

INTRODUCTION: In this secondary analysis of the Metformin and AcaRbose in Chinese as the initial Hypoglycaemic treatment (MARCH) trial, we evaluated what demographic and clinical factors were associated with reduction in weight. We also assessed the effects of acarbose and metformin treatment on wei...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Na, Zhang, Jin-Ping, Xing, Xiao-Yan, Yang, Zhao-Jun, Zhang, Bo, Wang, Xin, Yang, Wen-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425198/
https://www.ncbi.nlm.nih.gov/pubmed/30899282
http://dx.doi.org/10.5114/aoms.2018.75255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425198/
https://www.ncbi.nlm.nih.gov/pubmed/30899282
http://dx.doi.org/10.5114/aoms.2018.75255

Ejemplares similares